AUTHOR CONTRIBUTIONS O.H.T., M.G.H., and J.D. designed the study. N.V.R. designed and performed the experiments identifying TDP-43 targets in SH-SY5Y cells. R.S. designed and performed the experiments on the UCSD ALS patient samples. J.R. provided the UCSD ALS patient samples and associated clinical and diagnostic data. In the NYGC ALS Consortium, members contributed ALS patient samples and clinical information. D.K. curated de-identified clinical data and C9orf72 genotype information. I.H. and N.P. coordinated study materials and processed samples for sequencing. S.F. oversees Consortium resources and data distribution. D.F. and H.P. designed the methodology, reviewed sample preparation and data quality, and coordinated the research activity of NYGC ALS Consortium postmortem core RNA-seq experiments. B.T.H. supervised the neuropathological analysis of the immunohistochemical staining results. L.W.O. coordinated the post-mortem tissue, slide, and data collection through the Target ALS Multicenter Post-Mortem Tissue Core and assisted in analysis of the immunohistochemical staining results. O.H.T. and M.G.H. analyzed the data. All authors contributed to the interpretation, writing, and editing of the manuscript.